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Abstract: Lactic acid bacteria (LAB) produce many different antimicrobial proteins, some of which
have potential in food preservation. The molecular analysis of bacteriocins has gained much attention
and has advanced rapidly in recent years, and it became routine to analyze the way in which
bacteriocins are expressed and translocated. Since they are associated with foods of plant and animal
origins, the shared interest is that they can be utilized as a vector to deliver the active constituents at
the target in the gastrointestinal tract after digestion and be used in therapy. In this respect, the
molecular pattern of the expression and translocation of salivaricin B (SalB), a bacteriocin, from
Lactobacillus salivarius M7 was studied at the molecular level. The gene encoding SalB and the
flanking sequences were obtained and sequenced. The gene encoding SalB comprised an open reading
frame (ORF) of 171 bp having a 57 bp long leader sequence and a 114 bp long structural part.
Ribosomal binding site (GAGG, RBS) is located at a cannonical distance of 8 bp upstream from the
start site.
Key Words: Gene, Gene structure, Salivaricin B, PCR, Inverse PCR, Degenerate primers, Lactobacillus
salivarius M7.

Salivarisin B Aktivitesini Kodlayan Gen ve Çevre Nükleotid S›ralar›n›n
Moleküler Karakterizasyonu
Özet: Laktik asit bakterileri (LAB) baz›lar› g›da korunmas›nda kullan›lan birçok farkl› antibakteriyel
protein üretirler. Bakteriosinlerin moleküler genetik analizleri son y›llarda oldukça ilgi çekmifl ve
h›zlanm›flt›r. Buna paralel olarak bakteriosinlerin ekspresyon ve sal›n›mlar› rutin olarak incelenmeye
bafllanm›flt›r. Bitki ve hayvan kökenli g›dalarla birlikte bulunduklar›ndan ortak amaç bu bakterilerin bir
vektör olarak kullan›lmas›n› ve tafl›d›klar› aktif içeri¤i gastrointestinal sistemin hedef bölgesinde
sal›verilmelerini sa¤lamak ve tedavide kullanabilmektir. Bu bak›mdan bu çal›flmada Lactobacillus
salivarius M7 taraf›ndan sentezlenen ve bir bakteriosin olan salivarisin B (SalB)’nin ifade edilmesi ve
hücre d›fl›na naklinin moleküler yap›s› ortaya ç›kar›larak incelenmifltir. SalB’yi kodlayan gen ve
çevreleyen bölge elde edilerek nükleotid dizilimi aç›¤a ç›kar›lm›flt›r. Buna göre SalB’yi kodlayan gen
171 baz çiftinde meydana gelmekte, 57 bazl›k bir lider s›raya ve 114 bazl›k bir gen yap›sal bölgesine
sahiptir. Bafllang›ç baz çiftinden 8 nukletid uzakta ise bilinen ribosom ba¤lama bölgesi (RBS)
yerleflmifltir.
Anahtar Sözcükler: Gen, Gen moleküler yap›s›, Salivarisin B, PCR, Inverse PCR, Dejenere primerler,
Lactobacillus salivarius M7.
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Introduction
Lactic acid bacteria have been used in the production of fermented foods and feeds
throughout the history of humankind (1). In addition to being recognized for their health and
nutritional benefits, they are now beginning to gain industrial importance in terms of the
preservation of highly perishable foods of plants and animal origins. Lactic acid bacteria show
a strong antagonistic activity against many food spoiling microorganisms and pathogens
including listeria, clostridia, staphylococci, and streptococci. Besides the production of lactic acid
as the primary metabolite, resulting in a decrease in the pH of the food to be fermented, some
strains also produce inhibitory substances called bacteriocins.
In view of the growing consumer demand for natural food additives, most applied research
has been focused on the possibility of using either these bacteria or the products of them,
bacteriocins, as natural food additives. Recently, Lactobacillus salivarius M7 was isolated from
the dental plaque of rodents (2), its physiology has been studied (3), and the amino acid
sequence of its logarithmic phase product salivaricin B (SalB), a bacteriocin, was partially
identified (4). In order to obtain the whole sequence information of the gene encoding the SalB
activity from L. salivarius M7, this report describes the isolation of chromosomal DNA, the
amplification of the sequence where the related gene lies by Inverse PCR, and sequencing the
fragment obtained by Inverse PCR with the technique called cycle sequencing (5).

Materials and Methods
Cell Growth

Lactobacillus salivarius M7 were propagated in MRS (de Man Rogosa Sharpe) broth (Difco
Laboratories, Detroit, Michigan) at 37°C overnight. Eschericia coli was propagated in LB (Luria
Bertani) broth (Difco) at 37°C overnight as well.
DNA Preparation
The genomic DNA was isolated by using the technique of Posno et al. (1991). Lactobacillus
salivarius M7 was grown overnight in MRS medium containing 40 mM DL threonine at 37°C.
Cells were pelleted. The pellet was resuspended in 1 ml, 20 mM maleate buffer and centrifuged
again. Supernatant was discarded and the pellet was freeze-dried at -20°C for 1 h. The pellet
was resuspended in 0.6 M lactose/20 mM maleate buffer containing 2 mg lysosyme/ml and
incubated in a waterbath for 1 h at 37°C. The cells were centrifuged at 12,000 rpm for 10
min. The pellet was resuspended in 400 µl 120 mM Tris·HCl (pH 8.0). Addition of 88 µl of 0.5
M EDTA was followed by 110 µl 5% sarcosyl. The mixture was incubated at 37°C for 10 min.
After 200 µl 5 M NaCl was added. Equal amounts of phenol:chloroform (150 µl) were added.
The mixture was shaken smoothly on a rotary shaker for 5 min followed by incubation on ice
for 5 min. Two volumes of absolute alcohol and 200 µl 3 M NaCl were added and centrifuged
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(Hettich) at 12,000 rpm for 5 min. The pellet was washed with 70% EtOH and vacuum dried
for 10 min. The DNA was dissolved in 450 µl 0.1X SSC. 8 µl RNAse (10 mg/ml) was added to
the mixture and incubated at 65°C for 20 min. The addition of 52 µl 5 M NaCl was followed
by phenol-chlorophorm extraction. Final precipitation was carried out with 2 volumes of EtOH
and 3 M NaCl at –20°C at maximal speed. The pellet was washed with 70% EtOH and vacuum
dried (Gallenkamp). The DNA was dissolved in 100 µl Milli-Q water.
Restriction Enzyme Digestion
Genomic DNA was digested with Ase I, Bgl II, Bam HI, Eco RI (Gibco BRL), Hin d III, and
Sau 3A1 (New England, Biolabs). Each reaction mixture was incubated overnight at 37°C. The
reaction mixture contained 10 µg genomic DNA, 10 µl of reaction buffer, 5 µl (10 U/µl ) of
enzyme, and 60 µl Milli-Q water (7).
Ligation
A total of 20 µl of digestion product, 10 µl buffer for T4 DNA ligase (Bohringer, Mannheim),
and 4 µl T4 DNA ligase was added to each tube containing the reaction mixture and the tubes
were incubated at 14°C overnight (7).
Inverse PCR
Based on the already known DNA sequence, a set of four non-degenerate perfectly matching
primers were synthesized and Inverse PCR amplifications were carried out with divergent
primers (Bioscience). Several primer sets were used for Inverse PCR amplifications. The primer
OC95R, 5’-GGATGTACAATCGCTAATAC-3’ was used in combination with OC96F, 5’TCAAAAGATTAAGACATTCAAATC-3’. The primer, OC95R, was also used in combination with
OC94F, 5’-TAGAGGAAGGAAGAGATATG-3’ as well as OC97R, 5’-CCATCTAACCAGATATTCCA3’. The reaction mixture was prepared to a final volume of 50 µl including 5 µl of 10X reaction
buffer, 20 mM of each dNTP, 2 mM MgCl2, 2 U Taq polymerase (Perkin Elmer, USA), 1 µl of
each primer (50 rmol) and 50 ng of template DNA. The reaction conditions were as follows: 6
min of hot start at 95ºC, 30 seconds of melting at 95ºC, 50 seconds of annealing at 49ºC, and
3 min of extension at 72ºC. The reaction was performed for 35 cycles. Inverse PCR products
were purified using a clean kit (Qiagen) after agarose gel electrophoresis. Amounts of 200-500
nM purified cycle sequencing amplification products were loaded on the sequencer and used in
sequencing (5) (ABI Prism 310, Applied Biosystems, Foster City, USA).

Results
Amplification product of a 550 bp sequence (Figure 1) generated from lygated Ase I cut
sites was purified, sequenced, and showed to contain the open reading frame (ORF) coding for
the salB gene. However, in the ORF of the salB gene there was an insertion of almost 100bp
(Figure 2). One last perfectly matching primer OC98F (a 21-mer) was synthesized and used
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Lanes

Figure 1.

1 2 3 4 5 6 7

Base pair

Ase I digested fragment of 550
bp obtained by Inverse PCR
amplifications is in lane 1;
marker DNA pEMBL-8 is in
lane 7.
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AGATTAGAAG AAATAGTCAA AAAGAGCAGA TGAAGTGAAT AATTATAAGT
OC98F
GTAAATTATA GCTATAATAA ATTTTTAAAA TTATGAGGTG TTGAAGTTAT
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AATACCAAAT TTTTCAAAAG ATTAAGACAT TCAAATCAAA ATATTTGTAG
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TTAAACAGAA ATGTAACCAA CTAGGTATAA AACATTTTAT GCTAAATTGA
CGGAATGATA ATACAATAAA AGTGTAAGCA TATGTTTCAC AAGTGTTTTA
GAGAGGATGT GTTCTATGTG TATGGAATAT CTGGTTAGAT GGCGGATTAA
OC97R
TTAGAGGAAG GAAGAGATAT GTAATCATTC CAATTATTTT TGCAATATTT
CTTCCCCAAT

Figure 2.
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550 bp long product of cycle sequencing and four primers used in Inverse PCR amplifications. Partial
amino acid sequence of salivaricin B is given under the nucleotide sequence.
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with (OC97R) in forward PCR amplifications. The PCR product was purified and directly
sequenced. A fragment of 500 bp was obtained (Figure 3). This fragment contained the ORF1
coding for SalB precursor protein and an additional ORF further downstream. The analysis of
the nucleotide sequence revealed that the actual size of the petide is 38 amino acids. This was
contrary to the previous findings of Bart ten Brink, (1995). The ORF1 was found to start with
the ATG codon at position 86. The coding sequence of salB comprised 171 nt and 57 of which
code for the leader peptide of 19 amino acid. The actual peptide did not contain the leader
peptide. The leader peptide ends with a double glycine motif at positions –2 and –1, which are
preceded by two isoleucine residues at positions –4 and –3. A ribosome binding site, RBS
(GAGG), locates at a cannonical distance of 8 nucleotides from the +1 position. Immediately
downstream of the ORF1 the second ORF is located. The second ORF also starts with an RBS
followed by another start codon.

Discussion
Nucleotide sequence analysis revealed that salivaricin B was synthesized as a precursor
protein of 57 amino acids. It has a leader peptide of 19 amino acids. The lack of 19 amino acid
leader sequence from the mature protein suggests that on its way to the cell surface, just
before release, the leader peptide cleaves itself off the rest of the protein. The leader peptide
contains the cannonical double glycine motif for signal sequence independent (sec-independent)
translation and translocation of the bacteriocin. Preceding the double glycine leader sequence
at positions –3 and –4, there are two isoleucine residues.
Thus, the presence of a strongly conserved cleavage site with a double glycine motif
indicates that salivaricin B produced by L. salivarius M7 belongs to the class II LAB bacteriocins
as well (8). A comparison of amino acid sequences of the other bacteriocins confirmed this
notion. As is known, the class II bacteriocins contain positively charged residues (Lys or Arg) at
positions +1 and +2. The amino acid sequence of salivaricin B conforms to these patterns only
for the N-terminal part of its sequence. Although the amino acid sequences at positions 4 to 11
of salivaricin B do not show much similarity to the consensus sequence (Tyr-Gly-Asn-Gly-ValXaa-Cys) in the N-terminal region of the anti-listerial bacteriocins, such as acidocin A (9),
carnobacteriocin BM1 (10), curvacin A (11), it has a strong antilisterial activity to all listeria
species tested (data not included). Thus, it is conceivable that salivaricin B belongs to the class
II LAB bacteriocins, though may not follow the same structural fashion found in the anti-listeria
family. Comparisons of the primary structure of the purified peptide with the salB structural
gene indicates that salivaricin B is synthesized as a precursor protein. As is known, precursor
proteins are translated and processed by three apparently distinct mechanisms: formation of
dehydroresidues, thioester cross bridging, and proteolytic cleavage. The first two features are
mainly utilized by the lantibiotics, a group of bacteriocins that contain unusually formed amino
acids, whereas the last feature is utilized by bacteriocins of class II. The sequence of the
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AGATTAGAAGAAATAGTCAAAAAGAGCAGATGAAGTGAATAATTATAA
OC98 SAF
GTGTAAATTATAGCTATAATAAATTTTTAAAATTATGAGGTGTTGAAGT
RBS
TATGAATAATAATTTTATACAAGTTGATAAGAAAGAATTGGCACATATA
Start

N* N*

N* F*

I*

Q*

V* D*

K* K*

E*

L*

A* H* I*

ATTGGTGGAAGAAATTCTTATGATTATATAGATAGCGGACAGTTTGGTT
I* G* G*

R*

N* S*

Y* D* Y* I*

D*

S* G*

Q* F*

G*

Maturation site
ATGATATAGGATGTACAATCGCTAATACCAAATTTTTCAAAAGATTAAG
Y* D* I*

G* C*

T*

I*

A*

N* T*

K* F* F*

K*

R* L*

ACATTCAAATCAAAATATTTGTAGTTAAACAGAAATGTAACCAACTAGG
R* H* S*

N* Q* N* I*

C* S* Stop codon

TATAAAACATTTTATGCTAAATTGATATTTGAATACGGAATGATAATAC
AATAAAAGTGTAAGCATATGTTTCACAAGTGTTTTAGAGAGGATGTGT
2.Ribosome Binding site
TCTATGTGCTGAAAAAATTATGGAATATCTGGTTAGATGGCGGATTAAT
Start

OC97 SAR

TAGAGGAAGGAAGAGATATGTAATCATTCCAATTATTTTTGCAATATTTC
TTCCCCAAT
Figure 3.
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The complete nucleotide sequence of the 498 bp fragment carrying the gene coding for salivaricin B and
an additional ORF which is thought to be the gene encoding for the immunity protein. The letters starred
are the residues found in the original sequence of salivaricin B.
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maturation of class II bacteriocins or SalB is not currently known; however, accumulated data
suggest that the processing of SalB follows the following path: enzymatic modification,
proteolytic processing, and exportation. The salB gene started with the initiation ATG codon at
position 99. The putative ribosome binding (RBS) site, GGAGG, is present at cannonical distance
(8 bp upstream) from the ATG codon at nucleotide position 85. The salB gene encodes a 57amino-acid precursor that undergoes proteolytic cleavage of a 19-amino-acid leader peptide
sequence. This leader peptide of salB also has a high degree of homology to those of other class
II LAB bacteriocins (Figure 4). The Gly-Gly motif, which is typical among the class II LAB
bacteriocin precursors previously described, is found at the –1 and –2 positions before the
processing site. Also preceding the double glycine motif are the two isoleucine residues at
positions –3 and –4, and are accepted as the feature of class II LAB bacteriocins. These
similarities found among the leader peptides suggest that a common processing and/or
secretion mechanism for the class II LAB bacteriocins could exist. Analysis of the nucleotide
sequence revealed the presence of a second ORF, ORF2, immediately downstream from the
ORF1 for salB. For other well-characterized bacteriocins, it has been demonstrated that genes
involved in immunity functions are closely associated with the bacteriocin structural gene.
Therefore, it is highly likely that the ORF2 encodes a protein involved in immunity to salivaricin
B. To clarify the function of this ORF2-encoded protein, further investigation is obviously
required.
As mentioned above, the strong conservation of the cleavage site of the leaders strongly
suggests a common processing mechanism for these peptides (12). Another line of evidence
suggests that ABC-transporters are required for extracellular activation of class II bacteriocins
(13). Today it is well established that the secretion of double-glycine leader containing
bacteriocins is mediated by a dedicated transmembrane translocator belonging to the ATPbinding cassette (ABC) transporter superfamily (14).
The hydropathy plot of salivaricin B suggests that it is mostly a hydrophilic protein with 18
amino acids containing uncharged polar R-groups (15). Thus, outside of the cell, depending on
the presence of both positively and negatively charged residues, salivaricin B forms an
amphiphilic transmembrane helix with a hydrophobic inner core in the cell membrane of the
target bacterium. This view seems appropriate with the general structures of bacteriocins, as
they induce membrane spanning pore formation complexes to disturb the proton motive force
and the ion-exchange mechanisms of susceptible cells.
MNNNFIQVDKKELAHIIGG
The leader sequence

Glycine doublet

Figure 4.

The complete sequence of the
mature protein salivaricin B
From Lactobacillus salivarius
M7.

RNSYDYIDSGQFGYGIGCTIANTKFFKRLRHSNQNICS

385

Molecular Characterization of the Gene Encoding for the Salivaricin B Activity and its Flanking Sequences

Cycle sequencing of the fragments from the chromosomal DNA coding for salivaricin B
activity revealed a sequence of 550 nt. In the sequence, there were two consecutive ORFs. The
first one was of the salivaricin B peptide. The second ORF was thought to be the immunity
gene. The nucleotide sequence of the sal-B gene is composed of 171 nt. A 57 nt long leader
sequence codes for the 19 amino acid leader peptide. A glycine doublets are located in the –1
and –2 positions.
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